Alice Blue Home

Aliceblue News Desk

The Alice Blue Research Team is a passionate group of analysts delivering expert market insights, comprehensive coverage of stocks, economy, commodities, and personal finance through clear, actionable research.

Posts By Author

Zaggle stock in focus as company inks deals with IRM Energy and HDFC ERGO; details

Zaggle stock in focus as company inks deals with IRM Energy and HDFC ERGO; details

Zaggle Prepaid Ocean Services Limited signed a five-year Zaggle Fleet Program agreement with IRM Energy and a three-year Zaggle Propel reward platform agreement with HDFC ERGO.
IRB Infra Devs trades in green as ₹9,270 Cr TOT-17 project begins toll collection

IRB Infra Devs trades in green as ₹9,270 Cr TOT-17 project begins toll collection

IRB Infrastructure Developers Limited TOT-17 Project SPV, IRB Harihara Corridors, commenced tolling on NH-27 and NH-731 from 23 January 2026 after paying Rs. 9,270 crore concession fee.
AXISCADES Technologies gains 5% after landing $1 Mn hyperscaler deal via Mistral Solutions

AXISCADES Technologies gains 5% after landing $1 Mn hyperscaler deal via Mistral Solutions

AXISCADES Technologies Limited ESAI division, through subsidiary Mistral Solutions, won a $1 million multiyear contract from a Hyperscaler customer to test audio products in Aeroland Acoustic Lab.
This railway stock rallies 5% after bagging a ₹6 Cr order from Indian Railways

This railway stock rallies 5% after bagging a ₹6 Cr order from Indian Railways

Airfloa Rail Technology Limited has received a ₹6 crore order from Integral Coach Factory, Chennai, for AC ducts and equipment supply, to be completed within 90 days.
Corona Remedies moves up as company secures EAEU-GMP certification for global expansion

Corona Remedies moves up as company secures EAEU-GMP certification for global expansion

Corona Remedies Limited has received EAEU-GMP certification for its Bhayla facility, enabling exports to five EAEU nations and strengthening its global pharmaceutical presence.
Zydus Lifesciences gains as company launches world’s first Nivolumab biosimilar in India

Zydus Lifesciences gains as company launches world’s first Nivolumab biosimilar in India

Zydus Lifesciences Limited has launched Tishtha™, India’s first Nivolumab biosimilar, offering advanced Immuno-Oncology treatment at one-fourth the reference drug cost for cancer patients.
RailTel stock gains 3% after company bags major work order from Ministry of Defence

RailTel stock gains 3% after company bags major work order from Ministry of Defence

RailTel Corporation of India Ltd has received a ₹140.71 crore work order from the Ministry of Defence for annual maintenance services, to be executed by January 30, 2031.
Brahmaputra Infrastructure emerges lowest bidder for ₹46.62 Cr railway bridge work

Brahmaputra Infrastructure emerges lowest bidder for ₹46.62 Cr railway bridge work

Brahmaputra Infrastructure Limited has secured an L-1 order of ₹46.62 crore from NFR HQ-ENGG for constructing a Road over Bridge at Level Crossing NC-5.

No results found.

No results found.

Kick start your Trading and Investment Journey Today!

Other Authors

Set Up Your Account
in Just 15 Minutes

Pricing Chart
Trading App Screens Showing Zero Brokerage And Pricing Plans